These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


509 related items for PubMed ID: 26317782

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
    Johannsson G, Lennernäs H, Marelli C, Rockich K, Skrtic S.
    Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
    [Abstract] [Full Text] [Related]

  • 3. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
    Gow R, Koren G, Rieder M, Van Uum S.
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G, van Rossum EF, Vliegenthart J, Koper JW, van den Akker EL.
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M, Straub RH, Foppiani L, Prete C, Pulsatelli L, Sulli A, Boiardi L, Macchioni P, Giusti M, Pizzorni C, Seriolo B, Salvarani C.
    J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
    [Abstract] [Full Text] [Related]

  • 8. Increased Hair Cortisol Concentrations and BMI in Patients With Pituitary-Adrenal Disease on Hydrocortisone Replacement.
    Staufenbiel SM, Andela CD, Manenschijn L, Pereira AM, van Rossum EF, Biermasz NR.
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2456-62. PubMed ID: 25816049
    [Abstract] [Full Text] [Related]

  • 9. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F, Barbot M, Lizzul L, Selmin E, Saller A, Albiger N, Betterle C, Boscaro M, Scaroni C.
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
    Ekman B, Bachrach-Lindström M, Lindström T, Wahlberg J, Blomgren J, Arnqvist HJ.
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
    [Abstract] [Full Text] [Related]

  • 11. Low Impact of Urinary Cortisol in the Assessment of Hydrocortisone Replacement Therapy.
    Haas CS, Rahvar AH, Danneberg S, Lehnert H, Moenig H, Harbeck B.
    Horm Metab Res; 2016 Sep; 48(9):571-4. PubMed ID: 27300473
    [Abstract] [Full Text] [Related]

  • 12. DIAGNOSTIC ACCURACY OF BASAL CORTISOL LEVEL TO PREDICT ADRENAL INSUFFICIENCY IN COSYNTROPIN TESTING: RESULTS FROM AN OBSERVATIONAL COHORT STUDY WITH 804 PATIENTS.
    Struja T, Briner L, Meier A, Kutz A, Mundwiler E, Huber A, Mueller B, Bernasconi L, Schuetz P.
    Endocr Pract; 2017 Aug; 23(8):949-961. PubMed ID: 28614010
    [Abstract] [Full Text] [Related]

  • 13. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S.
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
    [Abstract] [Full Text] [Related]

  • 14. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C, Greco S, Nguyen HH, Ho JT, Lewis JG, Torpy DJ, Inder WJ.
    BMC Endocr Disord; 2014 Nov 26; 14():91. PubMed ID: 25425285
    [Abstract] [Full Text] [Related]

  • 15. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
    Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Olsson T, Ragnarsson O, Ryberg M, Wahlberg J, Biller BM, Monson JP, Stewart PM, Lennernäs H, Skrtic S.
    J Clin Endocrinol Metab; 2012 Feb 26; 97(2):473-81. PubMed ID: 22112807
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z, Rostami-Hodjegan A, Memmott A, Doane A, Ibbotson V, Newell-Price J, Tucker GT, Ross RJ.
    Clin Endocrinol (Oxf); 2006 Jul 26; 65(1):45-50. PubMed ID: 16817818
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.